Related Experiment Video
Updated: Jan 20, 2026

Quantitative Analysis of Climbing Defects in a Drosophila Model of Neurodegenerative Disorders
Published on: June 13, 2015
Microtubules: A Key to Understand and Correct Neuronal Defects in CDKL5 Deficiency Disorder?
Isabella Barbiero1, Roberta De Rosa1, Charlotte Kilstrup-Nielsen2
1Department of Biotechnology and Life Sciences, (DBSV), University of Insubria, Via Manara 7, 21052 Busto Arsizio (VA), Italy.
Abstract:
CDKL5 deficiency disorder (CDD) is a severe neurodevelopmental encephalopathy caused by mutations in the X-linked CDKL5 gene that encodes a serine/threonine kinase. CDD is characterised by the early onset of seizures and impaired cognitive and motor skills. Loss of CDKL5 in vitro and in vivo affects neuronal morphology at early and late stages of maturation, suggesting a link between CDKL5 and the neuronal cytoskeleton. Recently, various microtubule (MT)-binding proteins have been identified as interactors of CDKL5, indicating that its roles converge on regulating MT functioning. MTs are dynamic structures that are important for neuronal morphology, migration and polarity. The delicate control of MT dynamics is fundamental for proper neuronal functions, as evidenced by the fact that aberrant MT dynamics are involved in various neurological disorders. In this review, we highlight the link between CDKL5 and MTs, discussing how CDKL5 deficiency may lead to deranged neuronal functions through aberrant MT dynamics. Finally, we discuss whether the regulation of MT dynamics through microtubule-targeting agents may represent a novel strategy for future pharmacological approaches in the CDD field.
Insights
CDKL5 deficiency disorder (CDD) results from CDKL5 gene mutations, impacting brain development. This review explores how CDKL5 loss disrupts microtubule dynamics, potentially offering new therapeutic targets for CDD.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- CDKL5 deficiency disorder (CDD) is a severe neurodevelopmental disorder caused by mutations in the X-linked CDKL5 gene.
- CDD presents with early-onset seizures, cognitive impairment, and motor skill deficits.
- Loss of CDKL5 impacts neuronal morphology, suggesting a role in cytoskeletal regulation.
Purpose of the Study:
- To review the link between CDKL5 and microtubule (MT) dynamics.
- To discuss how CDKL5 deficiency may lead to aberrant MT dynamics and impaired neuronal function.
- To explore MT-targeting agents as potential therapeutic strategies for CDD.
Main Methods:
- Literature review focusing on CDKL5 function and MT regulation.
- Analysis of studies investigating CDKL5 interactors and their role in MT dynamics.
- Synthesis of evidence linking CDKL5 deficiency to neurological dysfunction via MTs.
Main Results:
- CDKL5 interacts with MT-binding proteins, converging its function on MT regulation.
- Aberrant MT dynamics are implicated in various neurological disorders, including CDD.
- CDKL5 deficiency disrupts neuronal morphology and function through altered MT dynamics.
Conclusions:
- CDKL5 plays a crucial role in regulating MT dynamics, essential for neuronal development and function.
- Dysregulation of MT dynamics is a key mechanism underlying CDD.
- Targeting MT dynamics may offer a novel therapeutic avenue for CDD.
Related Concept Videos
Microtubules
Key Elements for Plant Nutrition
Distance Corrections
Understanding the Self
Key Techniques in Microbiology
Power Factor Correction

